Follow
Preethy Prasad
Preethy Prasad
Verified email at utoronto.ca
Title
Cited by
Cited by
Year
Multifunctional Albumin–MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and …
P Prasad, CR Gordijo, AZ Abbasi, A Maeda, A Ip, AM Rauth, RS DaCosta, ...
ACS nano 8 (4), 3202-3212, 2014
5432014
Classification of cell types using a microfluidic device for mechanical and electrical measurement on single cells
J Chen, Y Zheng, Q Tan, E Shojaei-Baghini, YL Zhang, J Li, P Prasad, ...
Lab on a Chip 11 (18), 3174-3181, 2011
2302011
A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood–brain barrier targeting brain metastases of breast cancer
J Li, P Cai, A Shalviri, JT Henderson, C He, WD Foltz, P Prasad, ...
ACS nano 8 (10), 9925-9940, 2014
1572014
A Novel Solid Lipid Nanoparticle Formulation for Active Targeting to Tumor αvβ3 Integrin Receptors Reveals Cyclic RGD as A Double‐Edged Sword
AJ Shuhendler, P Prasad, M Leung, AM Rauth, RS DaCosta, XY Wu
Advanced healthcare materials 1 (5), 600-608, 2012
1162012
Colloidally stable silicon nanocrystals with near‐infrared photoluminescence for biological fluorescence imaging
EJ Henderson, AJ Shuhendler, P Prasad, V Baumann, F Maier‐Flaig, ...
Small 7 (17), 2507-2516, 2011
1102011
pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells
A Shalviri, G Raval, P Prasad, C Chan, Q Liu, H Heerklotz, AM Rauth, ...
European Journal of Pharmaceutics and Biopharmaceutics 82 (3), 587-597, 2012
1032012
Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts
P Prasad, A Shuhendler, P Cai, AM Rauth, XY Wu
Cancer letters 334 (2), 263-273, 2013
1002013
RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells
D Shan, J Li, P Cai, P Prasad, F Liu, AM Rauth, XY Wu
Drug delivery and translational research 5, 15-26, 2015
852015
Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model
AJ Shuhendler, P Prasad, RX Zhang, MA Amini, M Sun, PP Liu, ...
Molecular pharmaceutics 11 (8), 2659-2674, 2014
722014
Hybrid Quantum Dot−Fatty Ester Stealth Nanoparticles: Toward Clinically Relevant in Vivo Optical Imaging of Deep Tissue
AJ Shuhendler, P Prasad, HKC Chan, CR Gordijo, B Soroushian, ...
ACS nano 5 (3), 1958-1966, 2011
692011
Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer
AZ Abbasi, P Prasad, P Cai, C He, WD Foltz, MA Amini, CR Gordijo, ...
Journal of controlled release 209, 186-196, 2015
662015
Plant-based stearidonic acid as sustainable source of omega-3 fatty acid with functional outcomes on human health
P Prasad, P Anjali, RV Sreedhar
Critical Reviews in Food Science and Nutrition 61 (10), 1725-1737, 2021
612021
Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice
T Zhang, P Prasad, P Cai, C He, D Shan, AM Rauth, XY Wu
Acta Pharmacologica Sinica 38 (6), 835-847, 2017
582017
A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells
P Prasad, J Cheng, A Shuhendler, AM Rauth, XY Wu
Drug delivery and translational research 2, 95-105, 2012
462012
Matrigel alters the pathophysiology of orthotopic human breast adenocarcinoma xenografts with implications for nanomedicine evaluation
AJ Shuhendler, P Prasad, P Cai, KKW Hui, JT Henderson, AM Rauth, ...
Nanomedicine: Nanotechnology, Biology and Medicine 9 (6), 795-805, 2013
222013
RGD-conjugated nanoparticles for targeted inhibition of adhesion and migration of integrin αvβ3-overexpressing breast cancer cells.
D Shan, P Cai, P Prasad, AM Rauth, XY Wu
Cancer Research 73 (8_Supplement), 4339-4339, 2013
22013
A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa …
S Verma, H Sabbour, N Alamuddin, F Alawadi, H Alkandari, ...
Diabetes, Obesity and Metabolism 25 (6), 1444-1452, 2023
12023
Multifunctional nanoparticle compositions and uses thereof
X Wu, CR Gordijo, AZ Abbasi, P Prasad, MA Amini
US Patent 11,497,809, 2022
12022
Nanotechnology-Based Strategies To Enhance Chemo-And Radiation Therapy In Breast Cancer
P Prasad
University of Toronto (Canada), 2014
12014
Awareness and Perceptions Towards Inflammatory Risk in Atherosclerotic Cardiovascular Disease: A Multinational Survey Amongst Cardiologists
N Marx, I Komuro, AA Mohseni Zonoozi, P Prasad, J Qian, JF Saraiva, ...
Circulation 148 (Suppl_1), A12463-A12463, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20